Accéder au contenu
Merck

Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet.

Bioorganic & medicinal chemistry (2004-03-17)
Valérie Gagnard, Alain Leydet, Alain Morère, Jean-Louis Montero, Isabelle Lefèbvre, Gilles Gosselin, Christophe Pannecouque, Erick De Clercq
RÉSUMÉ

A new enzyme-labile group called S-acyl-3-thiopropyl group (SATP) has been synthesized from allylic esters of phosphonate. After demonstration of the enzyme-labile character of the SATP in cellular extracts, it has been introduced onto the phosphonate moiety of PFA (Foscarnet) to obtain potential lipophilic prodrugs. To ponder the lipophilicity of the triesters of PFA, esters of monomethylether of polyethyleneglycols and of thioglycerol were introduced on the PFA carboxylate moiety. The SATP groups were introduced in an attempt to deliver PFA after bioactivation inside the cells. The PFA prodrugs were evaluated in vitro for their activity against human immunodeficiency viruses (HIV-1 and HIV-2).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1-Thioglycérol, ≥97%
Sigma-Aldrich
1-Thioglycérol, liquid, BioReagent, suitable for cell culture, ≥97% (titration)
Sigma-Aldrich
1-Thioglycérol, ≥99.0% (GC)
Sigma-Aldrich
1-Thioglycérol, BioXtra, ≥97%